David Cassiman
Overview
Explore the profile of David Cassiman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
3014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koene E, Buziau A, Cassiman D, Cox T, Bons J, Scheijen J, et al.
J Clin Invest
. 2025 Feb;
PMID: 39932807
No abstract available.
2.
Mistry P, Cassiman D, Jones S, Lachmann R, Lukina E, Prada C, et al.
Hepatol Commun
. 2025 Jan;
9(1).
PMID: 39774103
Background: Acid sphingomyelinase deficiency (ASMD) and Gaucher disease type 1 (GD1) are rare inherited sphingolipid disorders with multisystemic manifestations, including liver disease and dyslipidemia. Despite effective treatments, insufficient disease awareness...
3.
Ott P, Sandahl T, Ala A, Cassiman D, Couchonnal-Bedoya E, Cury R, et al.
JHEP Rep
. 2024 Aug;
6(8):101115.
PMID: 39139457
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges...
4.
Buziau A, Oosterveer M, Wouters K, Bos T, Tolan D, Agius L, et al.
Mol Metab
. 2024 Jul;
87:101984.
PMID: 38972375
Objective: Stable isotope studies have shown that hepatic de novo lipogenesis (DNL) plays an important role in the pathogenesis of intrahepatic lipid (IHL) deposition. Furthermore, previous research has demonstrated that...
5.
Feio-Azevedo R, Boesch M, Radenkovic S, van Melkebeke L, Smets L, Wallays M, et al.
Hepatology
. 2024 May;
81(2):509-522.
PMID: 38761406
Background And Aims: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading...
6.
Derks B, Kumar V, Yadnik S, Panis B, Bosch A, Cassiman D, et al.
J Inherit Metab Dis
. 2024 Apr;
47(4):703-715.
PMID: 38659221
Patients with classic galactosemia (CG), an inborn error of galactose metabolism, suffer from impairments in cognition, including language processing. Potential causes are atypical brain oscillations. Recent electroencephalogram (EEG) showed differences...
7.
Vanderschueren E, Armandi A, Kwanten W, Cassiman D, Francque S, Schattenberg J, et al.
Am J Gastroenterol
. 2024 Mar;
119(8):1515-1524.
PMID: 38502095
Introduction: The Baveno VI criteria have set the stage for noninvasive assessment of compensated advanced chronic liver disease (ACLD). The algorithm combining liver stiffness measurement (LSM, <20 kPa) and platelet...
8.
9.
Vanlerberghe B, van Malenstein H, Sainz-Barriga M, Jochmans I, Cassiman D, Monbaliu D, et al.
Transpl Int
. 2024 Mar;
37:12055.
PMID: 38440132
malignancy (DNM) is the primary cause of mortality after liver transplantation (LT) for alcohol-related liver disease (ALD). However, data on risk factors for DNM development after LT are limited, specifically...
10.
Panis B, Naomi Vos E, Baric I, Bosch A, Brouwers M, Burlina A, et al.
Front Genet
. 2024 Mar;
15:1355962.
PMID: 38425716
Classic galactosemia (CG, OMIM #230400, ORPHA: 79,239) is a hereditary disorder of galactose metabolism that, despite treatment with galactose restriction, affects brain function in 85% of the patients. Problems with...